Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf J Ludwig

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
ISRN Dermatology|August 20, 2013
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisitaRalf J Ludwig
Current Drug Discovery Technologies|December 23, 2009
Therapeutic use of heparin beyond anticoagulationRalf J Ludwig
Autoimmunity|September 20, 2011
Model systems duplicating epidermolysis bullosa acquisita: a methodological reviewRalf J Ludwig
Experimental Dermatology|March 8, 2017
Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisitaRalf J Ludwig
Dermatologic Clinics|May 25, 2011
Pathogenesis of epidermolysis bullosa acquisitaRalf J Ludwig, Detlef Zillikens
Acta Dermato-Venereologica|February 11, 2020
Drug Development in Pemphigoid DiseasesKatja Bieber, Ralf J Ludwig
Lancet (London, England)|October 9, 2007
How shingles can be beachedRalf J Ludwig, Roland Kaufmann
Journal of the American Academy of Dermatology|February 25, 2023
Reply to: "Interpreting with caution the lack of association between isotretinoin, depression, and suicide"Khalaf Kridin, Ralf J Ludwig
Journal of the American Academy of Dermatology|May 5, 2023
Reply to comment on: "Isotretinoin and the risk of psychiatric disturbances - A global study shedding new light on a debatable story"Khalaf Kridin, Ralf J Ludwig
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2023
Forschung für die Praxis: Ernährung und Mikrobiom bei AutoimmunkrankheitenArtem Vorobyev, Ralf J Ludwig
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
ISRN Dermatology|August 20, 2013
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisitaRalf J Ludwig
Current Drug Discovery Technologies|December 23, 2009
Therapeutic use of heparin beyond anticoagulationRalf J Ludwig
Autoimmunity|September 20, 2011
Model systems duplicating epidermolysis bullosa acquisita: a methodological reviewRalf J Ludwig
Experimental Dermatology|March 8, 2017
Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisitaRalf J Ludwig
Dermatologic Clinics|May 25, 2011
Pathogenesis of epidermolysis bullosa acquisitaRalf J Ludwig, Detlef Zillikens
Acta Dermato-Venereologica|February 11, 2020
Drug Development in Pemphigoid DiseasesKatja Bieber, Ralf J Ludwig
Lancet (London, England)|October 9, 2007
How shingles can be beachedRalf J Ludwig, Roland Kaufmann
Journal of the American Academy of Dermatology|February 25, 2023
Reply to: "Interpreting with caution the lack of association between isotretinoin, depression, and suicide"Khalaf Kridin, Ralf J Ludwig
Journal of the American Academy of Dermatology|May 5, 2023
Reply to comment on: "Isotretinoin and the risk of psychiatric disturbances - A global study shedding new light on a debatable story"Khalaf Kridin, Ralf J Ludwig
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2023
Forschung für die Praxis: Ernährung und Mikrobiom bei AutoimmunkrankheitenArtem Vorobyev, Ralf J Ludwig
Pageof 34